|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/10 | (2006.01) |
| A61K 47/32 | (2013.01) | ||
| A61K 31/4152 | (2006.01) | ||
| A61K 9/10 | (2013.01) | ||
| A61K 47/32 | (2006.01) | ||
| A61K 47/36 | (2013.01) | ||
| A61K 47/36 | (2006.01) | ||
| A61K 31/4152 | (2013.01) | ||
| A61K 47/38 | (2006.01) | ||
| A61K 47/38 | (2013.01) | ||
| A61P 21/02 | (2006.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 21/02 | (2018.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61K 9/0095 | (2013.01) |
| (11) | Number of the document | 3875085 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19880770.3 |
| Date of filing the European patent application | 2019-11-01 | |
| (97) | Date of publication of the European application | 2021-09-08 |
| (45) | Date of publication and mention of the grant of the patent | 2024-06-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2019/043013 |
| Date | 2019-11-01 |
| (87) | Number | WO 2020/091036 |
| Date | 2020-05-07 |
| (30) | Number | Date | Country code |
| 2018207646 | 2018-11-02 | JP |
| (72) |
HAYAMA, Tetsuo , JP
TAKAHASHI, Tomohiro , JP
OMURA, Tomoyuki , JP
HAYASHI, Kouji , JP
MATSUDA, Munetomo , JP
MIYAZAWA, Tadashi , JP
|
| (73) |
Mitsubishi Tanabe Pharma Corporation ,
3-2-10, Dosho-machi,
Chuo-ku,, Osaka-shi,
Osaka 541-8505,
JP
|
| (54) | EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION |
| EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION |